Centre for cellular and molecular biology, Research institute in Hyderabad, India

MCON Rasayan India Ltd Initial Public Offering (IPO) got fully subscribed within hours of opening on the first day. Driven by strong response from Retails, the RII portion was subscribed 23.41 times and the NII portion was subscribed 7.42 times on Day 1. At 3:30 pm, for the total Issue size of 17,10,000 equity shares, the total bids received was 2,56,44,000 equity sharesMCON Rasayan India Limited specializes in manufacturing, marketing, and distributing contemporary building materials and construction chemicals. It boasts a comprehensive product portfolio (more than 80 products) that caters to various construction applications, from foundation to finishing. In contrast to its competitors involved in the cement or paint industry, MCON Rasayan stands out as one of the few players in the country with such a diverse product range, available at a competitive price point. Also, The company had introduced eight (8) innovative products in the past three (3) years either independently or in consultation with their clients.Mahesh Bhanushali, the CMD of the company on this occasion expressed his gratitude and appreciation for the overwhelming response received from investors. He stated that the strong demand reflects the investors' trust and confidence in the company's growth prospects, innovative products, and excellent management team.GYR Capital Advisors Private Limited is the Lead Manager to the Issue. The IPO is available for subscription from March 06, 2023, to March 10, 2023. The Equity shares offered through this IPO are proposed to be listed on the EMERGE platform of the NSE on March 20th, 2023.The promoter and promoter group shareholding will be 66.64 per cent post-IPO, from 91.45 per cent pre-IPO. The company proposes to utilize the funds towards funding the working capital requirements of the company and General corporate purposes.Incorporated in 2013, MCON Rasayan India Ltd., has two manufacturing units and a strong presence in three states, majorly in Maharashtra, Gujarat and Rajasthan with 100 distributors and 1300 retailers. The products are marketed and sold under the "MCON" brand and their clients are developers, civil contractors and architects.The construction chemical market is considerably fragmented. As per the CareEdge Report (Construction & Construction Chemicals industry dated June 2022), the industry is expected to maintain its momentum of growth driven by its untapped potential and growth of the construction industry in coming years. With increasing new construction activities and repair and rehabilitation technologies, the demand for construction is likely to make parallel growth. The high import cost of construction chemicals brings an opportunity for the domestic industry to expand and manufacture greater and more advanced products and solutions.Disclaimer: MCON RASAYAN INDIA LIMITED is proposing, subject to market condition and other considerations, a public issue of its Equity shares and has filed the prospectus with the registrar of companies, Mumbai ("ROC"). The prospectus is available on the website of SEBI (www.sebi.gov.in), website of the Issuer Company (www.mconrasayan.com), the website of the Lead Manager to the Issue (www.gyrcapitaladvisors.com) and on the website of National Stock Exchange of India Limited (www.nseindia.com). Investor should note that investment in equity shares involves high degree of risk. For details, investor should refer to and rely on the prospectus, including the section titled "RISK FACTOR" on page no. 26 of the prospectus, which has been filed with RoC, before making any investment decision.The equity shares have not been and will not be registered under the US Securities Act of 1933, as amended (the "securities act") and may not be offered or sold within United States (as defined in regulations under the Securities Act) except pursuant to an exemption from, or in a transaction not subject to, the registration requirement of the Securities Act. The equity shares are being offered and sold only outside the United States in offshore transaction in compliance with regulations under the Securities Act and the applicable laws of the jurisdiction where those offers and sales occurs.Link for prospectus: https://www1.nseindia.com/emerge/corporates/content/MCONRasayan_PROSP.pdfThis story is provided by PNN.will not be responsible in any way for the content of this article. (ANI/PNN)( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Centre For Cellular And Molecular BiologyFOLLOW

Centre for cellular and molecular biology, Latest News

New Delhi, March 7 Hockey India on Tuesday announced an ambitious new Grassroots Development Programme, designed to unearth ... ...

Namashi Chakraborty’s Rowdy Dance and Amrin Qureshi’s prettiness In Bad Boy teaser, rings in the naughty Holi ardour New ... ...

Chandigarh, March 7 Haryana Chief Minister Manohar Lal Khattar said on Tuesday that as part of the campaign ... ...

Security at the Lucknow Charbagh railway station has been beefed up ahead of Holi, with the Director of the ... ...

There were 1000 women attendees from schools, colleges, medical colleges and pharmaceutical backgrounds at the town hall talk The ... ...

L&T Financial Services (LTFS), one of the leading Non-Banking Financial Companies, has recognised its outperforming employees with Star Awards, the highest recognition for service in the Company. This award is given to employees who are not only the ...

New Delhi, March 7 Congress President Mallikarjun Kharge has alleged that the per capita income growth is a ... ...

MCON Rasayan India Ltd Initial Public Offering (IPO) got fully subscribed within hours of opening on the first day. Driven by strong response from Retails, the RII portion was subscribed 23.41 times and the NII portion was subscribed 7.42 times on Da ...